[HTML][HTML] Prophylactic and therapeutic HPV vaccines: current scenario and perspectives

Y Mo, J Ma, H Zhang, J Shen, J Chen… - Frontiers in Cellular …, 2022 - frontiersin.org
Persistent human papillomavirus (HPV) infection is recognized as the main cause of cervical
cancer and other malignant cancers. Although early detection and treatment can be …

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post …

PS Naud, CM Roteli-Martins… - Human vaccines & …, 2014 - Taylor & Francis
HPV-023 (NCT00518336; ClinicalTrial. gov) is a long-term follow-up of an initial double-
blind, randomized (1: 1), placebo-controlled study (HPV-001, NCT00689741) evaluating the …

Present status of human papillomavirus vaccine development and implementation

R Herrero, P González, LE Markowitz - The lancet oncology, 2015 - thelancet.com
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

Safety of human papillomavirus vaccines: an updated review

A Phillips, C Patel, A Pillsbury, J Brotherton… - Drug safety, 2018 - Springer
Human papillomavirus (HPV) vaccines are now included in immunisation programmes in 71
countries. Unfortunately, uptake has been impacted in some countries by reduced …

[HTML][HTML] Safety of COVID-19 vaccines during pregnancy: a systematic review and meta-analysis

A Ciapponi, M Berrueta, EPK Parker, A Bardach… - Vaccine, 2023 - Elsevier
Background Assessment of COVID-19 vaccines safety during pregnancy is urgently needed.
Methods We conducted a systematic review and meta-analysis to evaluate the safety of …

Long-term efficacy and safety of human papillomavirus vaccination

R De Vincenzo, C Conte, C Ricci… - … journal of women's …, 2014 - Taylor & Francis
In this paper, we review the published evidence about the long-term efficacy of the available
human papillomavirus (HPV) vaccines and their safety profile. Two prophylactic HPV …

[HTML][HTML] Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

M DeSilva, FM Munoz, M Mcmillan, AT Kawai… - Vaccine, 2016 - ncbi.nlm.nih.gov
Disclaimer: The findings, opinions and assertions contained in this consensus document are
those of the individual scientific professional members of the working group. They do not …

Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage

JML Brotherton, PN Bloem - Best practice & research Clinical obstetrics & …, 2018 - Elsevier
Persistent oncogenic human papillomavirus (HPV) is the cause of cervical cancer, as well as
cancers of the anus, penis, vulva, vagina and oropharynx. There is good evidence that …

[HTML][HTML] Do vaccines have a role as a cause of autoimmune neurological syndromes?

N Principi, S Esposito - Frontiers in public health, 2020 - frontiersin.org
Vaccines are the most important preventive measure against infectious diseases presently
available. Although they have led to the eradication or the elimination of some infectious …